![]() |
市場調查報告書
商品編碼
1577229
魚油市場至2030年的預測:按產品類型、應用和地區分類的全球分析Fish Oil Market Forecasts to 2030 - Global Analysis By Product Type (Anchovy Oil, Salmon Oil Tuna Oil, Cod Liver Oil, Sardine Oil, Menhaden Oil, Krill Oil and Other Product Types), Type, Application and By Geography |
根據Stratistics MRC預測,2024年全球魚油市場規模將達31億美元,預計2030年將達到46億美元,預測期內年複合成長率為6.6%。
魚油是從富含脂肪的魚類組織中提取的膳食食品,富含二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)等Omega-3脂肪酸。 Omega-3脂肪酸的主要益處包括降低血壓和三酸甘油酯(可促進心血管健康)、促進認知能力和大腦健康,以及減少發炎(可改善關節炎等疾病)。它還具有發炎特性並支持整體健康。魚油有液體和錠劑兩種形式,是希望透過食用天然Omega-3來源來改善健康的人們的首選。
據 IFFO(海洋原料組織)表示,中國是世界上最大的吳郭魚生產國,並將這種魚類出口到美國。
消費者對健康益處的認知不斷增強
由於人們越來越重視預防性醫療保健,消費者開始轉向魚油等營養食品,作為預防關節炎和心臟病等慢性疾病的積極措施。這一趨勢凸顯了補充品作為健康生活的必要組成部分的重要性。此外,由於人們認知的提高,魚油現在已包含在機能性食品中,使消費者能夠在不大幅改變飲食的情況下增加Omega-3 的消費量。
與植物性Omega-3來源的競爭
有意識的消費者會被亞麻仁油和藻油等植物性替代品所吸引,它們比魚油便宜。由於魚油產品由於採購和製造成本而昂貴,因此市場佔有率受到這種價格優勢的限制。消費者對植物來源Omega-3來源的偏好日益增加,因為它們被認為是道德且永續的,這是永續性和健康趨勢不斷變化的結果。魚油市場的擴張可能會受到這項變化的阻礙。
慢性病增加
由於憂鬱症、關節炎和心血管疾病等長期健康問題對補充品的需求增加,補充品的銷售量不斷增加。魚油作為一種預防藥物越來越受歡迎,尤其是在更容易患有慢性病的老年人中。隨著醫療保健轉向預防,魚油被認為是均衡飲食的重要組成部分。
污染風險
由於戴奧辛、多氯聯苯和汞等毒素,消費者對魚油補充品的不信任增加了監管機構的警覺性。 FDA 和其他健康組織就食用某些類型的魚類時存在污染風險發出警告,因此對魚油生產實施了更嚴格的監管。這種壓力可能會影響製造商的成本和供應鏈,減少市場總需求。
COVID-19 大流行對魚油市場產生了各種影響。最初,停工對供應鏈和生產設施造成了嚴重干擾,導致原料採購和產品分銷延遲。然而,隨著消費者尋求增強免疫力的產品,對魚油補充品的需求激增。這種雙重效應帶來了滿足不斷成長的需求同時克服供應限制的挑戰,最終塑造了大流行期間和之後的市場動態。
預計鯷魚油產業在預測期內將是最大的
由於厄爾尼諾現像等環境波動對秘魯鯷魚漁業造成供應問題,導致生產力下降和成本上升,預計鯷魚油產業將在預測期內達到頂峰。魚油供應和市場價格受到這種稀缺的影響。然而,消費者對Omega-3脂肪酸的健康益處的認知增加了對鯷魚製成的產品的需求,鯷魚油的受歡迎程度直線上升。
Omega-3魚油領域預計在預測期內年複合成長率最高
由於預防保健的興起, Omega-3魚油產業預計在預測期內將呈現最高的年複合成長率, Omega-3魚油補充品現已成為日常生活的必需品。這種轉變使得魚油作為預防性健康措施而不是補充品變得更加重要。此外,研發活動的重點是增強Omega-3脂肪酸提取過程和採購方法的永續性,以滿足不斷成長的需求並解決環境問題。
由於北美水產養殖業的擴張,預計北美在預測期內將佔據最大的市場佔有率。這是因為水產飼料營養成分的改善取決於它。隨著美國和加拿大的衛生組織提倡增加 Omega-3 脂肪酸的消費,並鼓勵透過補充品和強化食品將魚油納入飲食中,製造商加強滿足不同的營養需求和消費者偏好。的產品範圍。
亞太地區在預測期內將呈現最高的成長率,因為該地區不斷擴大的中產階級增加了可支配收入,使他們能夠在魚油補充品等健康相關產品上花費更多。由於人口老化,特別是在日本等國家,對營養食品來管理慢性健康狀況的需求也在增加。此外,永續性和道德捕撈方法推動消費者信心和產業擴張。
According to Stratistics MRC, the Global Fish Oil Market is accounted for $3.1 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Extracted from the tissues of fatty fish, fish oil is a nutritional supplement that is high in omega-3 fatty acids, including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Its main benefits include lowering blood pressure and triglycerides, which promote cardiovascular health; enhancing cognitive performance and brain health; and reducing inflammation, which can help with illnesses like arthritis. Its anti-inflammatory qualities support general health. Fish oil, which is widely accessible in liquid and pill form, is a well-liked option for people looking to enhance their health by consuming natural omega-3 sources.
According to IFFO - The Marine Ingredients Organisation China is the largest producer of tilapia fish globally and exports this species to the U.S. Growing awareness about the health benefits of omega-3 in China has made the local population a prominent consumer of fish oil.
Increasing consumer awareness of the health benefits
Consumers are using dietary supplements like fish oil as proactive measures against chronic diseases like arthritis and heart disease as a result of the rising emphasis on preventive healthcare. This trend emphasizes how important supplements are as necessary elements of a healthy way of living. Furthermore, as a result of growing awareness, fish oil is now included in functional food items, enabling customers to up their omega-3 consumption without having to make major dietary changes.
Competition from plant-based omega-3 sources
Conscious customers are drawn to plant-based substitutes like flaxseed and algal oil since they are less expensive than fish oil. Because fish oil products are more expensive due to sourcing and production costs, their market share is limited by this price advantage. Growing consumer preference for plant-based omega-3 sources due to their perceived ethical and sustainable credentials is a result of shifting trends in sustainability and health. Fish oil market expansion may be hampered by this change.
Rising incidence of chronic diseases
Supplement sales are rising as a result of the growing demand for supplements brought on by long-term health issues like depression, arthritis, and cardiovascular illnesses. Fish oil is gaining popularity as a prophylactic, particularly among older populations who are more vulnerable to chronic illnesses. Fish oil is recognized as a vital part of a balanced diet as healthcare moves toward prevention.
Risk of contamination
The mistrust that consumers have for fish oil supplements as a result of toxins like dioxins, PCBs, and mercury has made regulatory agencies more vigilant. Stricter regulations for fish oil manufacturing are the result of warnings from the FDA and other health groups about the hazards of contamination when consuming specific types of fish. This pressure may have an effect on manufacturers' costs and supply chains, which may lower total market demand.
The COVID-19 pandemic has had a mixed impact on the fish oil market. Initially, it caused significant disruptions in supply chains and production facilities due to lockdowns, leading to delays in sourcing raw materials and distributing products. However, there was a surge in demand for fish oil supplements as consumers sought immune-boosting products. This dual effect has created challenges in meeting heightened demand while navigating supply constraints, ultimately shaping the market dynamics during and after the pandemic
The anchovy oil segment is expected to be the largest during the forecast period
The anchovy oil segment is expected to be the largest during the forecast period owing to environmental variables such as El Nino have caused supply issues for the Peruvian anchovy fishery, leading to decreased productivity and higher costs. Fish oil supply and market prices are impacted by this scarcity. However, the demand for products based on anchovies has increased due to consumer awareness of the health advantages of omega-3 fatty acids, which has led to a surge in the popularity of anchovy oil.
The omega-3 fish oil segment is expected to have the highest CAGR during the forecast period
The omega-3 fish oil segment is expected to have the highest CAGR during the forecast period due to the increase in preventive healthcare, and omega-3 fish oil supplements are now a necessary part of everyday life. This change emphasizes fish oil as a preventative health measure as opposed to a supplement. Additionally research and development activities are focused on enhancing extraction procedures and sustainability of sourcing practices for omega-3 fatty acids to fulfill growing demand and solve environmental concerns.
North America is expected to have the largest market share over the projection period due to the expanding aquaculture sector in North America. This is because improved aquafeed nutritional profiles depend on it. Health groups in the US and Canada are pushing for increased consumption of omega-3 fatty acids and urging people to include fish oil in their diets by way of supplements and foods that have been fortified thus to accommodate varying dietary requirements and consumer preferences, manufacturers are expanding the range of products they offer.
Asia Pacific is anticipated to witness the highest rate of growth during the forecast period due to higher disposable earnings brought about by the expanding middle class in Asia-Pacific nations enable customers to spend more on health-related goods like fish oil supplements. The need for nutritional supplements to manage chronic health disorders is also being driven by the aging population, especially in nations such as Japan. Additionally enhancing consumer confidence and driving industry expansion are sustainability initiatives and ethical fishing methods.
Key players in the market
Some of the key players in Fish Oil Market include Croda International plc, Ocean Group Ltd, GC Rieber, BASF SE, DSM, Sursan, Omega Protein Corporation, TripleNine, OLVEA Group, Pesquera Exalmar, Marvesa Holding N.V., Colpex International, Copeinca AS, FMC Corporation and Corpesca S.A.
In October 2024, BASF has introduced its new Emulgade(R) Verde line of natural-based emulsifiers for personal care at the SEPAWA Congress 2024. This innovative product line focuses on sustainable, naturally derived emulsifiers that are non-ethoxylated and suitable for a variety of applications.
In May 2024, DSM and Firmenich announced that they have entered into a business combination agreement (the "BCA") to establish the leading creation and innovation partner in nutrition, beauty and well-being ("DSM-Firmenich").